M-M-R II (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the M-M-R II drug offered from Merck Sharp & Dohme Corp.. This Live Attenuated Measles Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Measles Vaccine [Chemical/Ingredient],Live Attenuated Mumps Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Mumps Vaccine [Chemical/Ingredient],Live Attenuated Rubella Virus Vaccine [EPC],Actively Acquired Immunity [PE],Rubella Vaccine [Chemical/Ingredient],Vaccines, Attenuated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: measles, mumps, and rubella virus vaccine live
SUBSTANCE NAME: MEASLES VIRUS STRAIN ENDERS’ ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN
TYPE: VACCINE
PHARMA CLASS: Live Attenuated Measles Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Measles Vaccine [Chemical/Ingredient],Live Attenuated Mumps Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Mumps Vaccine [Chemical/Ingredient],Live Attenuated Rubella Virus Vaccine [EPC],Actively Acquired Immunity [PE],Rubella Vaccine [Chemical/Ingredient],Vaccines, Attenuated [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1971-04-21
END MARKETING DATE: 0000-00-00


M-M-R II VACCINE Details:

Item DescriptionM-M-R II from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 1000; 12500; 1000([TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL)
START MARKETING DATE: 1971-04-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-4681_d773f47d-06b4-4ba9-bb39-4b25e03e0c13
PRODUCT NDC: 0006-4681
APPLICATION NUMBER: BLA101069

Other MEASLES VIRUS STRAIN ENDERS’ ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name